A wave of insider buying hit US markets in June, with SMMT topping the list. Robert Duggan, Chairman and CEO of Summit Therapeutics, filed a $50M purchase on June 12. He bought 3.81 million shares at $13.12 each. That's a strong signal from the company's top executive.
John Malone kept buying LILA through late June. The Liberty Latin America director filed three separate purchases totalling nearly $10M. Shares were priced between $4.98 and $6.96, suggesting Malone sees deep value in the telecom holding company.
FBIN attracted a $13M buy from board-linked hedge fund Trian Partners. Ed Garden picked up 320,000 shares in Fortune Brands Innovations at $40.60 on June 10.
On the sell side, NVDA director Mark Stevens filed the disposal of $186M in shares on June 18. The WMT Walton Family Holdings Trust sold over $530M across two filings on June 16–18.
ASTS CEO Abel Avellan filed a $147M sale on June 23 — selling 2.5 million shares at $58.68. AMAT CEO Gary Dickerson also filed a $35M sell on July 1.
The pattern is clear: executives at high-flying names are trimming, while beaten-down stocks are attracting fresh buying at the top.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
